Finally, Cheng et al. provided evidence for the involvement of SLC25A47, a hepatic mitochondrial NAD+ transporter, in the regulation of the NAD+ levels, AMPKα activity and lipid metabolism in HCC cells. Here, SLC25A47 is linked to hepatocellular carcinoma.